OECD TG 416
OECD TG 416 is the standard for the ‘Two-Generation Reproduction Toxicity Study’, i.e. the two-generation reproduction toxicity study, which is included in Section 4 (Health Effects) of the OECD Test Guidelines for the Testing of Chemicals. The test aims to assess the effects of a test substance on reproductive functions, pregnancy, birth, lactation and the development of offspring across two consecutive generations (P, F1 and F2).
Note on regulatory status: OECD Guideline TG 416 has been withdrawn by the OECD and largely replaced by OECD Guideline TG 443 (Extended One-Generation Reproductive Toxicity Study, EOGRTS). Nevertheless, TG 416 continues to be used as a reference in certain regulatory frameworks when evaluating existing dossiers and interpreting historical two-generation data sets. For this reason, this service page covers both the scientific content of the guideline and its current practical application.
The basic principle of the test is to administer the test substance to male and female animals of the P generation, starting in the period prior to mating, to mate them and to produce the F1 generation. The F1 generation is also exposed to the test substance, mated, and the F2 generation is thus produced. In this way, the reproductive functions and development of the offspring are observed over two consecutive generations. The assessment is usually carried out on rats.
The key parameters assessed in the study are as follows:
Parent (P) and F1 generations – reproductive function:
- Gonadal function and the oestrus cycle
- Mating behaviour, mating and fertility indices
- Fertilisation and pregnancy indices
- Sperm parameters (count, motility, morphology)
- Histopathological examination of the reproductive organs
Pregnancy, birth and lactation:
- Gestation period and the course of labour
- Data on live births, stillbirths and resorption
- Lactation performance and survival rate of young animals
- Survival rate before and after weaning
Offspring generations (F1 and F2):
- Viability and survival rate after birth
- Body weight and growth chart
- Indicators of physical development (opening the eyes, teething, etc.)
- Where appropriate, recording of gender distribution and developmental abnormalities
- Reproductive performance of the F1 generation (production of the F2 generation)
The experimental design comprises a negative control group, a solvent control group and, where appropriate, a positive control group; the dosages, group size and duration of treatment are justified in accordance with the regulatory requirements of OECD Guideline 416.
Why is the study being carried out?
OECD Guideline 416 is implemented for the following scientific and regulatory purposes:
Assessment of reproductive toxicity: determination of the effects of the test substance on male and female fertility over two generations
Assessment of developmental effects: identification of effects occurring during pregnancy, birth and lactation
Monitoring intergenerational effects: Assessment of reproductive performance in the F1 generation and development in the F2 generationSupport for regulatory dossiers: Use in safety assessments of chemicals, pesticides, biocidal products and industrial chemicals; Analysis of historical data: Evaluation of existing TG 416 studies within the current regulatory context and comparison with TG 443 data; The ‘weight-of-evidence’ approach: Contribution to risk assessment in conjunction with further data on reproductive and developmental toxicity, physicochemical properties and exposure assessment
Although OECD TG 416 assesses reproductive functions and the development of offspring over two generations, its informative value with regard to functional developmental endpoints, endocrine disruption and late-onset effects is limited.
Consequently, current regulatory assessments are based on TG 443 and the associated guidelines. The results should be interpreted within the context of a holistic toxicological assessment.
We’ll take care of this
As part of our nano-testing services, we carry out tests in accordance with OECD TG 416, as well as the procedures set out in OECD TG 443 – the current equivalent of this standard – with scientific rigour within our accredited laboratory facilities and under our quality management system. Our scope of services includes the following:
Study design and protocol development
- Preparation of a test report in accordance with OECD TG 416 and its current equivalent, OECD TG 443
- Determination of the dosage range and definition of the main experimental design in accordance with the physicochemical properties of the test substance
- Determination of negative controls, solvent controls and, where appropriate, suitable positive control groups
- Scientific justification for the choice of species, route of administration, dosages and duration of treatment
- Compliance with ethical approval and animal welfare requirements
For your studies carried out in accordance with OECD TG 416 and its current equivalent, OECD TG 443, you can contact Nano-Test to obtain information on study design, species selection, sample acceptance criteria, the test schedule and reporting procedures.

